Fevertree Drinks PLC Block Listing Return

RNS Number : 7466Q

Fevertree Drinks PLC

03 June 2024

 

3 June 2024

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Block Listing Return

Name of applicant:		Fevertree Drinks plc
Name of schemes:		1)    Long Term Incentive Plan   2)    Savings Related Share Option Scheme
Period of return:	From:	2/12/2023	To:	3/6/24
Unallotted securities under scheme(s) from previous notification:		1)    1,262,786   2)    0
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		1)    0   2)    100,000
Less:  Number of securities issued/allotted under scheme(s) during period:		1)    41,900   2)    0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		1)    1,220,886   2)    100,000
Name of contact:		Andy Branchflower, Chief Financial Officer
Telephone number of contact:		[phone]

 

 

Ends

 

For further information:

 

Investor queries

Ann Hyams, Director of Investor Relations I [e-mail] I [phone]

 

Media queries

Oliver Winters, Director of Communications I [e-mail] I [phone]

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I [phone]

 

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I [phone]

 

Financial PR advisers - FGS Global

Faeth Birch [phone] I Anjali Unnikrishnan [phone]

 

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 85 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BLRFTMFTMTMMBII